Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Statin

Requiem for a Heavyweight: Big Brand Statin Era Comes to a Close as Crestor Heads Off-Patent

TCTMD - ‎13 hours ago‎
This month marks the end of an era: Crestor, once dubbed the “Super Statin” and the “Gorilla,” has lost its market exclusivity in the United States.

NKF: Are Statins Trouble for T2D Patients With Neuropathy?

MedPage Today - ‎11 hours ago‎
More than 600 patients with type 2 diabetic nephropathy -- 190 of them on statin therapy -- in a hospital in Saudi Arabia were included in the analysis.
See realtime coverage

Cholesterol levels, not statins, influence colorectal cancer risk

Science Daily - ‎Apr 26, 2016‎
Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of colorectal cancer, suggests a new, large case-control study from Penn Medicine researchers published this week in PLOS Medicine.

STATIN using technology to improve efficiency

Jamaica Observer - ‎Apr 28, 2016‎
DIRECTOR General at the Statistical Institute of Jamaica (STATIN), Carol Coy, says the entity has been making use of technology to improve the effectiveness and efficiency of operations.

Dr. Maryanne Demasi applauded for revealing statin controversy

Daily Mail - ‎May 3, 2016‎
Dr. Maryanne Demasi applauded for revealing statin controversy. Dr. Maryanne Demasi was applauded by an audience in Brisbane for exposing a statin con. Kendra Wilkinson shares her excitement... Read More · 0:16min · The Stones, Bob Dylan, and ...
See realtime coverage

A new alternative to statin side effects

KXAN.com - ‎Apr 24, 2016‎
AUSTIN (KXAN) - Statins, drugs like zocor, lipitor and crestor, are wonderful at lowering your cholesterol, in effect reducing your risk of a heart attack.
See realtime coverage

Spurious Link of Statins to Reduced Colorectal Cancer Risk

American Council on Science and Health - ‎Apr 27, 2016‎
For several years now, there has been limited and conflicting data showing a modest, but significant, protective effect conferred upon individuals on statin therapy, with respect to colon cancer. It seems, however, that these data were attributable to ...

Free speech vital in statin debate

The Hippocratic Post (blog) - ‎Apr 27, 2016‎
I'm afraid to say that Australians, and a large number of people in the UK and elsewhere around the world are not getting the same information about statins. I have long believed that statins, used to reduce high cholesterol, are not the 'wonder drugs ...

STATIN Plans Yearlong Celebrations to Mark 70th Anniversary

Government of Jamaica, Jamaica Information Service - ‎Apr 27, 2016‎
The Statistical Institute of Jamaica (STATIN) is celebrating its 70th anniversary this year and has planned a slew of activities to mark the milestone.

VIDEO: In patients with ACS, statin therapy provides necessary rapid plaque stabilization

Healio - ‎Apr 25, 2016‎
CHICAGO - Karol Watson, MD, PhD, director of the UCLA Barbra Streisand Women's Heart Health Program, discusses the role of statin therapy in the acute setting following an ACS. After highlighting the clear CVD prevention benefits being reaped from the ...

LDL Improvement in Hypertriglyceridemia Depends on Statin

Renal and Urology News - ‎Apr 25, 2016‎
HealthDay News - For patients with hypertriglyceridemia, low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) reductions depend of the choice and dose of statin, according to research published in the May 1 issue of The American Journal ...

Disclosing coronary heart disease risk improves shared decision making on statin therapy

Cardiovascular Business - ‎Apr 25, 2016‎
A post-hoc analysis of a randomized study found that intermediate-risk participants who had a family history of coronary heart disease and received a genetic risk score were more likely to take statins. Lead researcher Maya S. Safarova, MD, PhD, of the ...
See realtime coverage

OptiBiotix interesting big pharma with statin-free cholesterol pill

The Pharma Letter (registration) - ‎Apr 26, 2016‎
UK biotech OptiBiotix (LSE: OPTI) has been in talks with big pharma about a cholesterol pill believed to work as well as statins, but without the side effects, according to reports. British newspaper The Times reported market interest in OptiBiotix's ...

LDL reduction in hypertriglyceridemia varies per statin

Medical Xpress - ‎Apr 20, 2016‎
(HealthDay)—For patients with hypertriglyceridemia, low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) reductions depend of the choice and dose of statin, according to research published in the May 1 issue of The American Journal of ...

LDL Cholesterol, Triglyceride Reductions in Hypertriglyceridemia Vary by Statin

Endocrinology Advisor - ‎Apr 22, 2016‎
(HealthDay News) - For patients with hypertriglyceridemia, LDL cholesterol, and triglyceride reductions depend of the choice and dose of statin, according to research published in The American Journal of Cardiology. Björn W. Karlson, MD, PhD, from ...

STATIN gets $10 Million for 2016 Household Expenditure Survey

Government of Jamaica, Jamaica Information Service - ‎Apr 20, 2016‎
The Statistical Institute of Jamaica (STATIN) has been allotted a sum of $10 million to undertake data collection/analysis to assist with activities relating to the 2016 Household Expenditure Survey.

CardioBrief: Rosuvastatin Goes Generic, Major Role Expected

MedPage Today - ‎May 2, 2016‎
Over time, as the price of rosuvastatin drops with generic competition, it seems likely that the dominant statin in the market for 2 decades -- atorvastatin (Lipitor) -- will cede a significant portion of its share to rosuvastatin.

Nearly half of heart bypass patients skip medications that keep blood flowing

Science Daily - ‎8 hours ago‎
Researchers at Thomas Jefferson University discovered that nearly half of coronary artery bypass patients are not taking statins and aspirin together when they are referred for diagnostic cardiac catheterization at least three years after their initial ...

Unexplained fall in cholesterol could be sign of colorectal cancer

The Pharmaceutical Journal - ‎Apr 29, 2016‎
They believe their analysis suggests that the previously reported link between statin use and reduced risk of colorectal cancer may be explained by indication bias - the bias that results from treatment choices being made according to a patient's ...
See realtime coverage

FDA approves first generic Crestor

FDA.gov - ‎Apr 29, 2016‎
Rosuvastatin calcium is in a class of drugs called statins, which work by stopping an enzyme called HMG-CoA reductase from making cholesterol.
 -